Hepatitis Weekly articles from March 2009

Hepatitis Weekly archives from March 2009

A potential marker of increased histological activity in hepatitis C virus infection.
March 2, 2009... Early, vigorous and sustained lymphocyte proliferative responses specific to hepatitis C virus (HCV) have been regarded as pivotal for viral clearance. On the other hand, antibody responses' contribution is still controversial. Research data...

What are the histologic features of intrahepatic neonatal cholestasis?
March 2, 2009... Cholestatic neonatal jaundice can be the initial manifestation of a very heterogeneous group of illnesses of different etiologies; many of them are potentially serious condition that indicates hepatobiliary dysfunction. The rapid detection of...

Studies from University of London provide new data on blood safety.
March 2, 2009... "Acupuncture is in widespread use in China, a country where the prevalence of infection with hepatitis B (HBV) is high and that of other bloodborne viruses is growing. Policies to reduce iatrogenic transmission have so far focused on...

Researchers at Research Center release new data on hematopoietic.
March 2, 2009... According to recent research from Riyadh, Saudi Arabia, "Although several centers are now performing allogeneic hematopoietic SCT (HSCT) in the Eastern Mediterranean (EM) region, the availability is still limited. Special issues including...

Findings from INSERM in hepatitis reported.
March 2, 2009... "Chronic viral hepatitis is a prolonged inflammatory disease of the liver that may lead to the development of fibrosis, necro-inflammation and other associated pathological features. Because fibrosis and its end-point cirrhosis are the main...

Research on hepatitis described by scientists at University of Georgia.
March 2, 2009... "A series of 7-deazaneplanocin A (7-DNPA, 2) analogues were synthesized and evaluated for in vitro antiviral activity against HBV and HCV," scientists writing in the Journal of Medicinal Chemistry report (see also Hepatitis). "The...

Findings from University of Calgary broaden understanding of hepatitis B virus.
March 2, 2009... "The two main goals of hepatitis B therapy are durable viral suppression and avoidance of antiviral resistance. Recent treatment guidelines now recognize the importance of these treatment endpoints in the prevention of end-stage liver disease...

New data from University of Messina illuminate research in hepatitis B virus.
March 2, 2009... "The role of hepatitis B (HBV) and C (HCV) virus infection in mortality among MHD patients is poorly understood. Recent studies have shown that HCV positivity is associated with significantly higher cardiovascular mortality, especially in...

New findings from K. Madan and co-authors in the area of hepatitis B virus published.
March 2, 2009... "Association of HBV genotypes (especially A and D) with severity of liver disease is controversial. We studied the influence of HBV genotypes on liver disease severity among Indian patients," researchers in New Delhi, India report (see also...

New hepatitis B virus study results from Fudan University described.
March 2, 2009... According to recent research from Shanghai, People's Republic of China, "Total ethanol extract and saponins from Chinese herb Radix Astragali (Huangqi) have been previously shown to possess anti-hepatitis B virus (HBV) activities in vitro. To...

Research from Chang-Gung University broadens understanding of hepatitis B virus.
March 2, 2009... "Chronic hepatitis B virus (HBV) infection is a dynamic state of interactions among HBV, the hepatocytes and the immune system of the patient. Perinatally or early childhood-acquired chronic HBV infection has a long 'immune tolerant phase',...

Research from G.J.B. Sonder and co-authors yields new data on hepatitis B virus.
March 2, 2009... According to recent research published in the Journal of Travel Medicine, "Behavioral studies in travelers suggest that 33% to 76% of all travelers to hepatitis B virus (HBV)-endemic countries are at risk for HBV infection. We study the...

Research on hepatitis B virus described by scientists at Columbus Children's Hospital.
March 2, 2009... "Hepatitis B infection during pregnancy presents a unique set of management issues. Aspects of care that must be considered include maternal and fetal effects of hepatitis B, effects of pregnancy itself on the course of hepatitis B infection...

Research on hepatitis B virus detailed by scientists at INSERM.
March 2, 2009... "The management of hepatitis B virus resistance to antivirals has evolved rapidly in recent years. The definition of resistance is now well established, with the importance of partial response and the improvement of assays to detect genotypic...

Researchers from University of Hong Kong detail findings in hepatitis B virus.
March 2, 2009... "Worldwide, chronic hepatitis B virus infection is a major cause of end-stage liver disease and hepatocellular carcinoma. While the past two decades have brought major advances in the availability of treatments to help delay or prevent these...

Researchers from University of Milan discuss findings in hepatitis B virus.
March 2, 2009... According to a study from Milan, Italy, "Antiviral therapy is aimed to persistently suppress hepatitis B virus (HBV) to prevent liver complications and improve survival and long-term administration of nucleos(t)ide analogues represents an...

Researchers from Zhengzhou University provide details of new studies and findings in the area of hepatitis B virus.
March 2, 2009... According to recent research from People's Republic of China, "The gene encoding MAP30 protein was cloned from bitter melon and recombinant MAP30 was expressed and purified. The human hepatoma G2.2.15 cells were exposed to different...

Studies from University of Oxford provide new data on hepatitis B virus.
March 2, 2009... "The first proteomic characterization of the HepaRG cell line, the only cell line that is susceptible to hepatitis B virus (HBV) infection and supports a complete virus life cycle, is reported. Differential analysis of naive and HBV-infected...

Study data from Drexel University provide new insights into hepatitis B virus.
March 2, 2009... According to recent research published in the Journal of Virology, "Recognition of virus infections by pattern recognition receptors (PRRs), such as Toll-like receptors (TLRs), retinoic acid-inducible gene I (RIG-I), and melanoma...

Data on hepatitis C virus discussed by researchers at Emory University, Emory Children's Center.
March 2, 2009... "The most frequent reason for orthotopic liver transplantation (OLT) in the United States is due to complications of hepatitis C (HCV). Recent reports have shown decreased survival for HCV after OLT," scientists writing in the journal...

New hepatitis C virus data have been reported by L. Urbani and co-authors.
March 2, 2009... According to recent research published in the journal Transplantation, "Donor's age and immunosuppression influence the severity of hepatitis C virus (HCV) recurrence. We analyzed the 18-month mortality in 302 consecutive HCV recipients,...

New hepatitis C virus research from Keio University, Medical Department described.
March 2, 2009... According to recent research from Tokyo, Japan, "We investigated lipid metabolism in patients with chronic hepatitis C virus (HCV), serotype 1, undergoing combination therapy with PEG-IFN alpha-2b (PEG-IFN) and ribavirin (RBV). A total of 185...

New hepatitis C virus research from M. Houghton and colleagues discussed.
March 2, 2009... According to a study from the United States, "After nearly 6 years of intensive investigations between 1982 and 1988 in my laboratory at Chiron corporation, in which numerous molecular biological methods were used to investigate the viral...

New hepatitis C virus research from University of California, Medical Department described.
March 2, 2009... "Hepatitis C virus (HCV) F protein is encoded by the +1 reading frame of the viral genome. It overlaps with the core protein coding sequence, and multiple mechanisms for its expression have been proposed," investigators in the United States...

New hepatitis C virus research from University of Virgen of Rocio discussed.(Report)
March 2, 2009... "The outcome of chronic hepatitis C virus infection varies, depending on viral and host factors. Those mechanisms involved in the control of the innate and adaptive response could have an influence on the outcome of infection," researchers in...

New hepatitis C virus research reported from University of Valencia.(Report)
March 2, 2009... "Previous studies have shown that asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and nitric oxide (NO) play a prominent role in liver dysfunction. The objective of this study was to determine whether plasma levels of...

New hepatitis C virus study findings have been reported by researchers at F. Hoffmann-LaRoche Ltd.
March 2, 2009... "4'-Azidocytidine 3 (R1479) has been previously discovered as a potent and selective inhibitor of HCV replication targeting the RNA-dependent RNA polymerase of hepatitis C virus, NS5B," scientists in the United States report (see also Hepatitis...

New hepatitis C virus study findings have been reported from University of Adelaide.
March 2, 2009... According to a study from Adelaide, Australia, "To investigate chemokine expression networks in chronic hepatitis C virus (HCV) infection, we used microarray analysis to determine chemokine expression in human infection and in chimpanzees...

Recent findings in hepatitis C virus described by researchers from University of Padua, Medical Department.
March 2, 2009... "The natural history of chronic hepatitis C has been defined in several retrospective and prospective studies conducted in the last 20 years. These studies have clearly demonstrated that the outcome of chronic hepatitis C virus infection is...

Reports from Johann Wolfgang Goethe University describe recent advances in hepatitis C virus.
March 2, 2009... "Most infections with hepatitis C virus (HCV) fail to resolve spontaneously and progress to chronic hepatitis C. Genotype 1 HCV accounts for most hepatitis C infections in North America, Western Europe, and Japan. Patients infected with HCV...

Reports from S.M. Kamal et al highlight recent research in hepatitis C virus.
March 2, 2009... "Hepatitis C virus genotype 4 (HCV-G4) is prevalent in the Middle East and Africa and has spread to several regions in Europe. HCV-G4 represents a major health problem in Egypt, with a prevalence rate of 13%," scientists in Cairo, Egypt report...

Reports from University of Birmingham describe recent advances in hepatitis C virus.
March 2, 2009... "Hepatitis C virus (HCV) primarily replicates within the liver, leading to hepatitis, fibrosis, and hepatocellular carcinoma. Infection is also associated with B-cell abnormalities, suggesting an association of the virus with B cells,"...

Reports from University of Palermo advance knowledge in hepatitis C virus.
March 2, 2009... "Recently several randomized trials involving exclusively HCV 2 and 3 patients have explored the possibility of reducing the duration of therapy with PEG IFNs and ribavirin to 12-16 weeks. Among these, the largest studies (ACCELERATE, NORTH-C...

Research from S. Chevaliez and co-authors reveals new findings on hepatitis C virus.
March 2, 2009... According to recent research published in the journal Liver International, "Chronic hepatitis C is a global health problem that may cause cirrhosis and progression to hepatocellular carcinoma. Currently available antiviral treatments are...

Research from University of Minnesota in the area of hepatitis C virus published.
March 2, 2009... According to recent research published in the journal Clinical Transplantation, "The impact of a three-drug regimen including mycophenolate mofetil (MMF) vs. a two-drug (no MMF) regimen on progressive renal dysfunction (PRD) in liver transplant...

Research on hepatitis C virus detailed by L. Rossaro and co-authors.
March 2, 2009... According to recent research from the United States, "Patients with hepatitis C who live in rural and low socioeconomic communities often lack access to specialty care. Over the past 7 years, we have provided telemedicine consultations at the...

Research on hepatitis C virus detailed by scientists at Rockefeller University.
March 2, 2009... According to recent research from the United States, "Current treatment for chronic hepatitis C is expensive, is often accompanied by burdensome side effects, and, sadly, fails in almost half of cases." "The ability to predict such...

Researchers at Virginia Commonwealth University publish new data on hepatitis C virus.
March 2, 2009... According to a study from the United States, "The optimal therapy for patients with the chronic hepatitis C virus (HCV) is a combination of peginterferon and ribavirin. Treating HCV without ribavirin or prematurely discontinuing, frequently...

Researchers from St. Louis University, Medical Department describe findings in hepatitis C virus.
March 2, 2009... According to recent research from the United States, "Hepatitis C virus (HCV) is a common RNA virus that causes hepatitis and liver cancer. Infection is treated with IFN-alpha and ribavirin, but this expensive and physically demanding therapy...

Scientists at World Health Organization target hepatitis C virus.
March 2, 2009... "Hepatitis C is of concern both to industrialized and developing countries. Preliminary unpublished estimates of the global burden of disease (GBD) attributable to HCV-related chronic liver disease seem to be substantial," researchers in...

Scientists at Wuhan University describe research in hepatitis C virus.
March 2, 2009... According to recent research from Wuhan, People's Republic of China, "The hepatitis C virus is a major cause of chronic liver disease worldwide. Lack of culture system supporting virus production has been one of the major impediments in HCV...

Studies from University Hospital further understanding of hepatitis C virus.
March 2, 2009... "S. Dinges, I. Morard, M. Heim, J.-F. Dufour, B. Mullhaupt, E. Giostra, P.-A. Clavien, G. Mentha, F. Negro, for the Swiss Association for the Study of the Liver (SASL 17). Pegylated interferon-alpha(2a)/ribavirin treatment of recurrent...

Studies from University of Oxford have provided new data on hepatitis C virus.
March 2, 2009... According to a study from Oxford, the United Kingdom, "The hepatitis C virus (HCV), which currently infects an estimated 3% of people worldwide, has been present in some human populations for several centuries, notably HCV genotypes 1 and 2 in...

Study results from University of Toronto in the area of hepatitis C virus published.
March 2, 2009... According to recent research published in the journal Liver International, "All but about 10% of patients with chronic hepatitis C (CHC) (predominantly those infected with genotype 1) can respond to some degree to 'combination' therapy with...

Research from National University, Medical Department provides new data on hepatocellular cancer.
March 2, 2009... According to a study from Singapore, Singapore, "Hepatocellular carcinoma (HCC) is a major cause of cancer worldwide and is often characterized by aggressive tumour behaviour and poor prognosis. One of the major etiologies is hepatitis B or C...

Research from P. Marcellin and co-authors yields new data on hepatocellular cancer.
March 2, 2009... According to recent research from Clichy, France, "Hepatitis B virus (HBV) and hepatitis C virus (HCV) infections are among the most frequent viral infections in humans, and represent a major global public health problem. HBV- and HCV-related...

Research in the area of hepatocellular cancer reported from INSERM.
March 2, 2009... According to a study from Clichy, France, "Chronic hepatitis C is among the leading causes of chronicliver disease worldwide, with approximately 170 million people infected. The severity of disease varies from asymptomaticchronic infection to...

Research in the area of hepatocellular cancer reported from National University.
March 2, 2009... "Betel quid chewing, which contributes high concentration of safrole in saliva, is a popular oral habit in Taiwan. Safrole is a documented rodent hepatocarcinogen, yet its hepatocarcinogenic potential in human is not known," researchers in...

Researchers from Iwate Medical University report on findings in hepatocellular cancer.
March 2, 2009... According to a study from Morioka, Japan, "Prognosis is extremely poor for advanced hepatocellular carcinoma (HCC) in patients with portal invasion. The present study evaluated the efficacy of combined intra-arterial 5-fluorouracil (5-FU) and...

Studies from Yonsei University add new findings in the area of hepatocellular cancer.(Report)
March 2, 2009... According to recent research from Seoul, South Korea, "Brain metastases from hepatocellular carcinoma are extremely rare. The objectives of the current study were to assess the natural history, outcome, and possible prognostic factors in...

New findings from J.J. Snyder and co-researchers in the area of kidney transplants described.
March 2, 2009... According to a study from the United States, "We studied the incidence, trends and clinical correlates of infections following kidney transplantation in the United States Renal Data System over the years 1995-2003 in 46,471 adults with Medicare...

Reports from Kuwait University describe recent advances in obesity and diabetes.
March 2, 2009... According to a study from Kuwait, "A high occurrence of type 2 diabetes (T2D) in patients with chronic hepatitis C virus (HCV) infection has been reported in Kuwait and other countries. However, HCV genotype 4 has been underrepresented in all...

Researchers from Oswaldo Cruz Institute detail new studies and findings in the area of hepatitis A virus.(Report)
March 2, 2009... A new study, 'Should Brazilian patients with chronic hepatitis C virus infection be vaccinated against hepatitis A virus,' is now available. "Hepatitis A virus (HAV) superinfection is associated with a high risk of liver failure and death in...

Findings from Okayama University in hepatitis B virus therapy reported.(Clinical report)
March 2, 2009... Researchers detail in 'Efficacy and safety of entecavir in nucleoside-naive, chronic hepatitis B patients: phase II clinical study in Japan,' new data in hepatitis B virus. According to recent research published in the Journal of...

New hepatitis C virus findings from Mackay Memorial Hospital, Department of Dermatology described.
March 2, 2009... A report, 'Necrolytic acral erythema without hepatitis C infection,' is newly published data in Journal of Cutaneous Pathology. "Necrolytic acral erythema is a newly described entity characterized by sharply demarcated scaly plaques on the...

Research in the area of hepatitis C virus genetics reported from University of Tokyo, Department of Infectious Diseases.
March 2, 2009... New investigation results, 'Steatosis, liver injury, and hepatocarcinogenesis in hepatitis C viral infection,' are detailed in a study published in Journal of Gastroenterology. "In addition to the link with development of hepatocellular...

Recent findings in hepatitis C virus risk factors described by researchers from Tokyo Women's Medical University.
March 2, 2009... Data detailed in 'Clinical features and outcomes of cirrhosis due to non-alcoholic steatohepatitis compared with cirrhosis caused by chronic hepatitis C' have been presented. "Ethnic differences in non-alcoholic steatohepatitis (NASH) are...

Study data from Keio University, Department of Pathology provide new insights into life sciences.
March 2, 2009... Scientists discuss in 'Early HCC: diagnosis and molecular markers' new findings in life sciences. According to recent research from Tokyo, Japan, "Hepatocellular carcinoma (HCC) is one of the most common malignant tumors. HCC occurs mainly in...

Data on alcoholism reported by V. Stadlbauer and co-researchers.
March 2, 2009... According to a study from London, the United Kingdom, "Stadlbauer V, Mookerjee RP, Wright GA, Davies NA, Jurgens G, Hallstrom S, Jalan R. Role of Toll-like receptors 2, 4, and 9 in mediating neutrophil dysfunction in alcoholic hepatitis. Am J...

Reports from Keio University, Medical Department highlight recent research in alcoholism.(Report)
March 2, 2009... According to a study from Tokyo, Japan, "In patients with non-alcoholic fatty liver disease (NAFLD), liver biopsy remains the only reliable method to differentiate simple steatosis from non-alcoholic steatohepatitis (NASH). The objective of...

Researchers at University Medical Center have published new data on alcoholism.
March 2, 2009... "The prevalence of non-alcoholic steatohepatitis (NASH) is increasing. NASH confers an increased risk of liver-related morbidity and mortality with a substantial risk of developing liver cirrhosis," researchers in Hamburg, Germany report (see...

New coronavirus data have been reported by M. Kawase and co-authors.
March 2, 2009... According to a study from Tokyo, Japan, "Human coronavirus 229E, classified as a group I coronavirus, utilizes human aminopeptidase N (APN) as a receptor; however, its entry mechanism has not yet been fully elucidated. We found that HeLa cells...

Research in the area of eosinophilia reported from M. Eshki and colleagues.
March 2, 2009... According to recent research published in the journal Archives of Dermatology, "Factors implicated in the severity of drug reaction with eosinophilia and systemic symptoms (DRESS) have not been identified. We retrospectively describe and...

Findings from J.A. Daniels and co-authors broaden understanding of hepatitis.(Report)
March 2, 2009... "Primary biliary cirrhosis (PBC) is a chronic cholestatic liver disease characterized by inflammatory destruction of the intrahepatic bile ducts. The differential diagnosis for PBC often includes autoimmune hepatitis (AIH)," researchers in the...

Studies from Juntendo University, Medical Department in the area of hepatitis published.(Report)
March 2, 2009... "Activation of invariant NKT (iNKT) cells in the liver is generally regarded as the critical step for Con A-induced hepatitis, and the role of NK cell receptors for iNKT cell activation is still controversial. In this study we show that...

Studies from University of Milan reveal new findings on hepatocellular cancer.
March 2, 2009... According to a study from Milan, Italy, "Early diagnosis of hepatocellular carcinoma (HCC) is feasible because HCC develops in the background of well-known, readily identifiable and potentially avoidable environmental risk factors. According to...

Recent findings from Xiamen University, Department of Endocrinology highlight research in alcoholism.
March 2, 2009... Scientists discuss in 'Expression of adiponectin and its receptors in livers of morbidly obese patients with non-alcoholic fatty liver disease' new findings in alcoholism. "Obesity is one of the risk factors for non-alcoholic fatty liver...

Reports from Yamasa Corporation, Diagnostics Department add new data to research in alcoholism animal studies.
March 2, 2009... Current study results from the report, 'Marked elevation of serum mitochondrion-derived markers in mild models of non-alcoholic steatohepatitis in rats,' have been published. According to recent research from Choshi, Japan, "In order to find...

Researchers from Shanghai Institutes for Biological Sciences report recent findings in hepatitis therapy.(Report)
March 2, 2009... New investigation results, 'Tetrandrine protects mice from concanavalin A-induced hepatitis through inhibiting NF-kappaB activation,' are detailed in a study published in Immunology Letters. According to recent research from Shanghai, People's...

Scientists at University of Virginia, Digestive Health Center of Excellence publish new data on liver cancer epidemiology.
March 2, 2009... Researchers detail in 'The epidemiology of hepatocellular cancer: from the perspectives of public health problem to tumor biology,' new data in liver cancer. "The epidemiology of hepatocellular cancer (HCC) can be viewed from several important...

Abbott and Enanta Initiate Phase 1 Clinical Trial on ABT-450 HCV Protease Inhibitor.(Report)
March 2, 2009... Abbott (NYSE:ABT) and Enanta Pharmaceuticals announced the advancement of their Hepatitis C (HCV) collaboration with a first-in-human study evaluating ABT-450, an oral protease inhibitor for the treatment of chronic HCV. The objectives of the...

When acute hepatitis develops into chronic hepatitis.
March 2, 2009... To achieve this, Carlos A. Guzman, Head of the "Vaccinology and Applied Microbiology" working group and Robert Geffers, Head of the "Gene Expression Analysis" platform, examined the incidence and species of special defence cells, T helper...

InterMune Announces Issuance of U.S. Patent for ITMN-191.
March 2, 2009... InterMune, Inc. (NASDAQ:ITMN) announced the issuance of U.S. Patent Number 7,491,794, a composition of matter patent which covers the ITMN-191 (R7227) compound. The nominal 20-year patent term extends to October 13, 2024. ITMN-191 is an...

LabCorp is the First National Commercial Lab to Offer Roche's COBAS[R] AmpliPrep/COBAS[R] TaqMan[R] HCV Test.
March 2, 2009... Laboratory Corporation of America[R] Holdings (LabCorp[R]) (NYSE:LH) announces that it is the first national clinical laboratory to offer HCV PCR testing using a newly FDA approved assay, the Roche COBAS[R] AmpliPrep/COBAS[R] TaqMan[R] HCV...

Arnold Worldwide Entrusts Its Critical Data and Creative IP to Mimosa NearPoint Email Archiving Solution Stored on Compellent Storage Center.
March 2, 2009... Mimosa Systems, a leader in next-generation email and file archiving solutions, announced that the global advertising agency, Arnold Worldwide has deployed the Mimosa NearPoint(TM) archiving solution stored on Compellent's Storage Center(TM)...

Romark and Chugai Pharmaceutical Enter Into Exclusive Licensing Agreement for Nitazoxanide in Japan.
March 2, 2009... Romark Laboratories, a privately held biopharmaceutical company, and Chugai Pharmaceutical Co. Ltd., a member of the Roche Group, announced that the two companies have entered into an exclusive license agreement for the development and...

Findings from INSERM advance knowledge in acute hepatitis.
March 9, 2009... "Hepatitis E was found in people living in industrialized countries who had not travelled to highly endemic areas. To study the cases of acute hepatitis E confirmed thanks to vital genomic detection over a 5 years period in south-west France,"...

Study results from M. Baril and colleagues update understanding of antivirals.(Report)
March 9, 2009... According to recent research published in the Journal of Virology, "The mitochondrial antiviral signaling (MAVS) protein plays a central role in innate antiviral immunity. Upon recognition of a virus, intracellular receptors of the RIG-I-like...

New hepatitis study findings have been reported from Center for Satellite Applications and Research.
March 9, 2009... "The study of host-virus interactions that determine liver disease pathogenesis and outcome of infection have been key issues of interest in the field of viral hepatitis," scientists in Singapore, Singapore report (see also Hepatitis). "It...

Research from Tampere University yields new findings on hepatitis A virus.(Report)
March 9, 2009... "The aim of this study was to explore the relationship of exposure to hand-arm vibration (HAV) and vascular, sensorineural and musculoskeletal symptoms and symptoms of carpal tunnel syndrome (CTS) in a population of Finnish metalworkers. A...

New findings from Shandong University in the area of hepatitis B virus published.(Report)
March 9, 2009... "Killer immunoglobulin-like receptor (KIR) genes can regulate the activation of NK and T cells upon interaction with HLA class I molecules. Hepatitis B virus (HBV) infection has been regarded as a multi-factorial disorder disease," scientists...

New findings from Z.S. Zou and co-authors in the area of hepatitis B virus published.(Report)
March 9, 2009... "This Study attempts to determine expressions of intrahepatic proinflammatory and anti-inflammatory cytokines and their secreting immunocytes to evaluate their roles in the pathogenesis of acute-on-chronic liver failure (ACLF) in chronically...

New hepatitis B virus research from A. Mottacastro and co-researchers described.(Report)
March 9, 2009... "This study was conducted in an Afro-Brazilian, slave-descendant community with high (42.4%) hepatitis B virus (HBV) prevalence. Twenty (8.4%) out of the 239 subjects under study were HBsAg-positive, and HBV-DNA was detected in 59 (25%)...

New hepatitis B virus research has been reported by B.A. Borkentraven et al.(Report)
March 9, 2009... According to recent research from Netherlands, "To further reduce the risk of hepatitis B virus (HBV) transmission by blood transfusion, nucleic acid testing (NAT) can be employed. The aim of this study is to estimate the incremental...